Clinical Trial Update: Donor Stem Cell Transplant in Treating Patients With Hematologic Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update evaluating donor stem cell transplant for hematologic cancers, including leukemia and lymphoma, with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Leukemia
• Lymphoma
• Myelodysplastic Myeloproliferative Neoplasms
• Myelodysplastic Syndromes

Snippet

Sponsor: Case Comprehensive Cancer Center | Conditions: Leukemia, Lymphoma | Phase 2 | Status: COMPLETED | Results posted: 2013-07-24